{"data":{"id":"us/16-cfr-456.3","jurisdiction":"us","citation":"16 CFR 456.3","heading":"Verifiable affirmative consent to providing the prescription in a digital format.","body":"For a prescription copy provided in a digital format, the prescriber shall:\n(a) Identify to the patient the specific method or methods of electronic delivery that will be used, such as text message, electronic mail, or an online patient portal;\n(b) Obtain, on paper or in a digital format, the patient's verifiable affirmative consent to receive a digital copy through the identified method or methods; and\n(c) Maintain records or evidence of a patient's affirmative consent for a period of not less than three years. Such records or evidence shall be available for inspection by the Federal Trade Commission, its employees, and its representatives.","path":["Title 16—Commercial Practices","CHAPTER I—FEDERAL TRADE COMMISSION","SUBCHAPTER D—TRADE REGULATION RULES","PART 456—OPHTHALMIC PRACTICE RULES (EYEGLASS RULE)"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-16.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:29Z","sha256":"6e998cab14e67c69e497630ec6bcd24b79f26cb4fc23b8effc864e70e2582604","source_id":"us-cfr","stale":true,"prev":"us/16-cfr-456.2","next":"us/16-cfr-456.4"},"notice":"GroundRules: Original legal text. Not legal advice."}